Evaluation of Regenerative Endodontic Treatment for Immature Teeth
NCT ID: NCT07210359
Last Updated: 2025-10-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
36 participants
INTERVENTIONAL
2025-09-15
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Does the use of DDM improve clinical and radiographic outcomes such as root length, dentinal wall thickness, and apex closure?
Is DDM a viable bioactive alternative to RetroMTA as a coronal sealing material in regenerative endodontic procedures?
Researchers will compare three groups: one using RetroMTA, one using a DDM-TheraCal LC mixture, and one using TDM-Hydrogel, to see if these materials differ in their effects on regenerative outcomes.
Participants will:
Undergo two treatment visits including canal disinfection, induction of bleeding to form a blood clot scaffold,
Receive placement of one of the study materials over the blood clot as a coronal barrier,
Have clinical examinations and CBCT imaging at baseline and multiple follow-ups up to 12 months to assess treatment success through signs, symptoms, and radiographic changes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Regenerative Endodontic in Immature Permanent Teeth
NCT06006052
Comparison Between Emdogain and Amniotic Membrane as a Scaffold in Endodontic Regeneration of Immature Anterior Teeth
NCT07252167
Three Dimensional Evaluation of Apexogenesis of Immature Young Permanent Teeth With Different Endodontic Material
NCT05790629
Evaluation of Biodentine and Mineral Trioxide Aggregate in Revascularization of Non Vital Immature Anterior Teeth
NCT03589560
Evaluation of the Survival of Inflamed Mature Single Rooted Teeth
NCT03725514
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients will be divided randomly into three equal groups (n = 12):
Group 1(control group): Revascularization will be done using blood clot and RetroMTA as coronal barrier.
Group 2: Revascularization will be done using blood clot and DDM-TheraCal LC mixture paste as coronal barrier.
Group 3: Revascularization will be done using blood clot and TDM-Hydrogel as coronal barrier.
CBCT image will be obtained for baseline records before treatment and after placement of the final resin restoration, then the patients will be recalled after 3, 6, 9 and 12 months for evaluating any changes in dentin bridge formation, root length, root canal width, apex diameter and lesion size if present.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
treated hyman dentin matrix hydrogel
material used for regenerative dentistry
Theracal LC - Demineralized dentin matrix combination
material used for regenerative dentistry
Retro Mta
material used for regenerative dentistry
Theracal LC- Demineralized dentina matrix combination
material used for regenerative dentistry
human treated dentin matrix hydrogel
material used for regenerative dentistry
Retro Mta
material used for regenerative dentistry
RetroMTA
material used for regenerative dentistry
human treated dentin matrix hydrogel
material used for regenerative dentistry
Theracal LC - Demineralized dentin matrix combination
material used for regenerative dentistry
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
human treated dentin matrix hydrogel
material used for regenerative dentistry
Theracal LC - Demineralized dentin matrix combination
material used for regenerative dentistry
Retro Mta
material used for regenerative dentistry
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients presenting with immature permanent single-rooted teeth.
* Age: 9 -15 years.
* Teeth diagnosed as either vital (asymptomatic irreversible pulpitis or symptomatic irreversible pulpitis and the bleeding didn't stop after 5 minutes application of hemostatic agent) or non-vital pulp.
Exclusion Criteria
* Teeth that are grossly decayed or fractured and require post and core as final restorations
* Presence of periodontal pockets greater than 4 mm.
* Radiographical evidence of apical foramen less than 1 mm.
* Presence of periapical radiolucency exceeding 10 mm.
* Presence of external or internal root resorption.
* Patients with a history of major surgeries like cardiac, kidney transplantation, haemodialysis.
9 Years
15 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kafrelsheikh University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hisham Mahmoud Hamdy Abada
lecturer at Endodontic department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hisham Abada, Doctors
Role: PRINCIPAL_INVESTIGATOR
Academic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
KafrelsheikhU
Kafr ash Shaykh, Kafr Elsheikh, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
663
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.